SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy’s receives EIR from USFDA for Srikakulam plant

26 Feb 2018 Evaluate

Dr. Reddy’s Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its formulations facility at Srikakulam in the state of Andhra Pradesh.

USFDA has maintained Official Action Indicated (OAI) status at its API manufacturing plant at Srikakulam.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1306.75 -3.75 (-0.29%)
07-May-2026 13:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1836.70
Dr. Reddys Lab 1306.75
Cipla 1371.70
Zydus Lifesciences 939.65
Lupin 2464.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×